AmacaThera is a Toronto-based biotechnology company focused on developing and commercializing a unique, injectable hydrogel platform technology for a wide range of medical applications.
Based on the research of world-renowned biomaterials scientist, Dr. Molly Shoichet, AmacaThera is commercializing combination products at the interface of biomaterials and pharmaceuticals.
We have developed a platform technology which addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas.
Currently, we have developed a combination product for post-operative pain, which is our company's lead project.
Based on the research of world-renowned biomaterials scientist, Dr. Molly Shoichet, AmacaThera is commercializing combination products at the interface of biomaterials and pharmaceuticals.
We have developed a platform technology which addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas.
Currently, we have developed a combination product for post-operative pain, which is our company's lead project.
Location: Canada, Ontario, Toronto
Employees: 1-10
Total raised: $17.15M
Founded date: 2016
Investors 6
| Date | Name | Website |
| - | Lumira Ven... | lumiravent... |
| - | MaRS Inves... | marsiaf.co... |
| - | StandUp Ve... | standupvc.... |
| - | Canadian T... | ctaconnect... |
| - | MBX Capita... | mbxcapital... |
| - | BDC | bdc.ca/ |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 26.02.2021 | Series A | $10.3M | - |
| 08.10.2019 | Seed | $3.6M | - |
| 12.01.2019 | Seed | $3.25M | - |
Mentions in press and media 9
| Date | Title | Description |
| 08.07.2026 | Genesys University Seed Fund Holds First Close With Over $30 Million In Commitments | The University of Toronto, McMaster University, Venture Ontario, and Genesys Capital announced the creation of a new early-stage life sciences venture capital fund. The Genesys University Seed Fund has held a first close representing over $... |
| 04.12.2023 | Latest Updates of Viva's Portfolio Companies | HONG KONG, Dec. 4, 2023 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies ... |
| 24.02.2021 | Today in funding: AmacaThera, Elevate Farms, Snack, Maple | Three Canadian-associated startups have recently announced fresh funding rounds to fuel their growth. Here’s the latest on who raised, how much, from whom, and what they’ll be putting the new funds toward. AmacaThera raises $10.3 million Se... |
| 08.10.2019 | Hydrogel Platform Company AmacaThera Raises $3.6 Million In Seed Funding | AmacaThera, a hydrogel platform for sustained drug release, announced recently that it raised $3.6 million in seed funding AmacaThera — a hydrogel platform for sustained drug release — announced recently that it closed US$3.6 million in see... |
| 03.10.2019 | AmacaThera Closes US$3.6M Seed Financing Round | AmacaThera Inc., a Toronto, Canada-based focused on the commercialization of a hydrogel platform for sustained drug release, closed US$3.6M seed financing round. A first close of the round was led by Sprout BioVentures/ Viva Biotech with pa... |
| 03.10.2019 | AmacaThera Closes US$3.6 Million Seed Financing Round | TORONTO, Oct. 3, 2019 / PRNewswire/ — AmacaThera Inc. is pleased to announce the closing of its US$3.6 million seed financing round. A first close of the round was led by Sprout BioVentures/Viva Biotech with participation from Grey Sky Vent... |
| 21.01.2019 | AmacaThera raises $3.2 million for phase I of non-opioid pain control therapeutic | Toronto-based AmacaThera has raised $3.2 million in seed financing led by Sprout BioVentures, Viva Biotech, with additional participation from Grey Sky Venture Partners. The money will go towards advancing the company’s drug delivery platfo... |
| 12.01.2019 | AmacaThera Raises $3.25M in Seed Funding | AmacaThera, a Toronto, Canada-based company commercializing hydrogel-based drug delivery platforms, raised CAD$3.25m in seed financing. The round was led by Sprout BioVentures, Viva Biotech, with participation from Grey Sky Venture Partners... |
| - | AmacaThera | “Amacathera is developing an injectable hydrogel platform to provide localized, sustained drug delivery” |